Human metabolism and kinetics of tri-(2-ethylhexyl) trimellitate (TEHTM) after oral administration.

This study is the first to elucidate TEHTM metabolism pathways in humans and to identify metabolites of TEHTM in blood and urine by usage of especially designed human biomonitoring methods. Powerful tools for exposure monitoring and risk assessment of TEHTM are therewith available for future research. PMID: 30027468 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30027468?dopt=Abstract

Source: Archives of Toxicology - July 19, 2018 Category: Toxicology Authors: Höllerer C, Becker G, Göen T, Eckert E Tags: Arch Toxicol Source Type: research

More News: Medical Devices | Study | Toxicology